HLA-C as a mediator of natural killer and T-cell activation: Spectator or key player?

Immunology

Volumn 133, Issue 1, 2011, Pages 1-7

  Blais, Marie Eve ^a   Dong, Tao ^a   Rowland Jones, Sarah ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Epitopes; HIV; HLA C; Killer immunoglobulin receptors; T cells

Indexed keywords

EPITOPE; GAG PROTEIN; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MELANOMA ANTIGEN; MESSENGER RNA; NEF PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ALLOIMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; CRYSTAL STRUCTURE; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; GENE EXPRESSION PROFILING; GENE LINKAGE DISEQUILIBRIUM; GRAVES DISEASE; HEAVY CHAIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MYOSITIS; NASOPHARYNX CARCINOMA; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; REVIEW; SENDAI VIRUS; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TOXIC GOITER; UTERINE CERVIX CARCINOMA IN SITU;

ANIMALS; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 79953297495     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03422.x     Document Type: Review

References (48)

1. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998; 391:397-401.
2. Fellay J, Shianna KV, Ge D et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-7.
3. Goulder PJ, Bunce M, Luzzi G, Phillips RE, McMichael AJ. Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses. AIDS 1997; 11:1884-6.
4. Zemmour J, Parham P. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med 1992; 176:937-50.
5. Neisig A, Melief CJ, Neefjes J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol 1998; 160:171-9.
6. Turner S, Ellexson ME, Hickman HD, Sidebottom DA, Fernandez-Vina M, Confer DL, Hildebrand WH. Sequence-based typing provides a new look at HLA-C diversity. J Immunol 1998; 161:1406-13.
7. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med 1995; 181:2085-95.
8. Tibensky D, Decary F, Delovitch TL. HLA-C genes are transcribed in HLA-C blank individuals. Immunogenetics 1988; 27:220-4.
9. Neefjes JJ, Ploegh HL. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol 1988; 18:801-10.
10. Garcia-Ruano AB, Mendez R, Romero JM, Cabrera T, Ruiz-Cabello F, Garrido F. Analysis of HLA-ABC locus-specific transcription in normal tissues. Immunogenetics 2010; 62:711-9.
11. Sibilio L, Martayan A, Setini A, Lo Monaco E, Tremante E, Butler RH, Giacomini P. A single bottleneck in HLA-C assembly. J Biol Chem 2008; 283:1267-74.
12. Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986; 137:2299-306.
13. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000; 405:537-43.
14. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2001; 2:452-60.
15. Winter CC, Long EO. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 1997; 158:4026-8.
16. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996; 274:209-19.
17. Boyington JC, Sun PD. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 2002; 38:1007-21.
18. Matthews PC, Prendergast A, Leslie A et al. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 2008; 82:8548-59.
19. Falk K, Rotzschke O, Grahovac B et al. Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci U S A 1993; 90:12005-9.
20. Dill O, Kievits F, Koch S, Ivanyi P, Hammerling GJ. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc Natl Acad Sci U S A 1988; 85:5664-8.
21. Pei J, Akatsuka Y, Anasetti C, Lin MT, Petersdorf EW, Hansen JA, Martin PJ. Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements. Biol Blood Marrow Transplant 2001; 7:378-83.
22. Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. J Hepatol 2010; 52:712-7.
23. Khakoo SI, Thio CL, Martin MP et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305:872-4.
24. Parham P. Immunology. NK cells lose their inhibition. Science 2004; 305:786-7.
25. Cao J, McNevin J, McSweyn M, Liu Y, Mullins JI, McElrath MJ. Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance. J Virol 2008; 82:495-502.
26. Nair RP, Duffin KC, Helms C et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009; 41:199-204.
27. Ho PY, Barton A, Worthington J et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis 2008; 67:677-82.
28. Strange A, Capon F, Spencer CC et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010; 42:985-90.
29. Trowsdale J, Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol 2008; 20:317-20.
30. Apps R, Gardner L, Hiby SE, Sharkey AM, Moffett A. Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells. Immunology 2008; 124:322-8.
31. Sharkey AM, Gardner L, Hiby S et al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J Immunol 2008; 181:39-46.
32. Hiby SE, Walker JJ, O'Shaughnessy K M, Redman CW, Carrington M, Trowsdale J, Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957-65.
33. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008; 23:972-6.
34. Hiby SE, Apps R, Sharkey AM et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010; 120:4102-10.
35. Martin MP, Borecki IB, Zhang Z et al. HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics 2010; 62:761-5.
36. + T cells do not differ in polyfunctionality. Virology 2010; 405:483-91.
37. Makadzange AT, Gillespie G, Dong T et al. Characterization of an HLA-C-restricted CTL response in chronic HIV infection. Eur J Immunol 2010; 40:1036-41.
38. Adnan S, Balamurugan A, Trocha A, Bennett MS, Ng HL, Ali A, Brander C, Yang OO. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood 2006; 108:3414-9.
39. + T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variation. J Virol 2010; 84:11279-88.
40. Leslie A, Matthews PC, Listgarten J et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010; 84:9879-88.
41. Fellay J, Ge D, Shianna KV et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009; 5:e1000791.
42. Thomas R, Apps R, Qi Y et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 2009; 41:1290-4.
43. Liu Y, Helms C, Liao W et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008; 4:e1000041.
44. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999; 10:661-71.
45. Williams M, Roeth JF, Kasper MR, Fleis RI, Przybycin CG, Collins KL. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J Virol 2002; 76:12173-84.
46. Noviello CM, Benichou S, Guatelli JC. Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J Virol 2008; 82:1249-58.
47. Wonderlich ER, Williams M, Collins KL. The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail. J Biol Chem 2008; 283:3011-22.
48. Potter TA, Hansen TH, Habbersett R, Ozato K, Ahmed A. Flow microfluorometric analysis of H-2L expression. J Immunol 1981; 127:580-4.